| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in IONS over the last quarter tilts toward selling: insiders offloaded a net 196,094 shares worth roughly $15.4M.
Classified under Biotechnology (Health Care sector), IONS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 156.0K | $8.76M | - | |
| CEO | 99.9K | $5.61M | - | |
| CFO | 82.7K | $4.64M | - | |
| VP | 74.4K | $4.18M | - | |
| VP | 69.7K | $3.91M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sell | 1,207 | $32.35 | $39,046.45 | -2.1% | +2.5% | +154.4% | |
| Feb 4, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sell | 6,165 | $31.62 | $194,939.15 | -9.7% | +6.3% | +168.6% | |
| Feb 4, 2025 | Monia Brett P60 | Chief Executive Officer | Sell | 38,843 | $31.65 | $1,229,462.52 | -17.7% | +6.3% | +168.6% | |
| Jan 31, 2025 | Swayze Eric63 | EVP Research | Sell | 1,367 | $32.31 | $44,162.03 | -2.8% | -0.6% | +159.2% | |
| Jan 31, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sell | 1,406 | $32.49 | $45,684.60 | -2.2% | -0.6% | +159.2% | |
| Jan 31, 2025 | Monia Brett P60 | Chief Executive Officer | Sell | 13,242 | $32.45 | $429,655.23 | -5.7% | -0.6% | +159.2% | |
| Jan 31, 2025 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sell | 1,523 | $32.44 | $49,403.68 | -1.4% | -0.6% | +159.2% | |
| Jan 31, 2025 | Geary Richard S65 | EVP, Chief Development Officer | Sell | 1,406 | $32.40 | $45,561.29 | -1.4% | -0.6% | +159.2% | |
| Jan 31, 2025 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sell | 1,327 | $32.46 | $43,079.20 | -1.4% | -0.6% | +159.2% | |
| Jan 31, 2025 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sell | 1,484 | $32.20 | $47,779.90 | -2.4% | -0.6% | +159.2% |